Digital Health Global
AUGUST 15, 2023
–(BUSINESS WIRE)– #Biotech –Taking a people-first approach, BioscienceLA, the ecosystem accelerator for life sciences in Greater Los Angeles, has launched its inaugural Leadership Catalyst Program for trailblazers in biotechnology and related sectors.
Health Populi
JUNE 8, 2022
In 2018, Stacy launched her website, began blogging, and got social media traction when HIMSS appointed her a digital influencer. Parexel is a Clinical Research Organization that crafts and conducts clinical trials on behalf of life science companies. Parexel discovered Stacy who was delivering a keynote speech at DPHARM 2021.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Lloyd Price
JUNE 14, 2018
2018 Digital Health Prediction 2: Voice technology will be the first step to personalising pharma. 2018 Digital Health Prediction 3 : Healthbots will increasingly focus on solving automation problems in Healthcare, such as workflow data entry and fraud detection. After years of ambition, hype and hope.
Health Populi
MAY 20, 2021
Year-on-year, different spikes and ups-and-downs call out for special mention, such as: Pharma’s 13-point steep dive to 38% between 2017 and 2018, dramatically recovering by 9 points in the last year to 47% [with the wild card here of whether U.S. Hospitals’ fall from 70% to 63% between 2018 and 2019.
Healthcare IT Today
JANUARY 26, 2023
Foster joins Talent Group’s senior leadership team, along with Queen Vice Presidents, Jessica Doherty and Amy Migliore. ” Michael Babb, Managing Partner at Osceola Capital, investors in Talent Group, said, “This follows the acquisition of EdgeLink last year and is the fourth acquisition since our initial investment in 2018.
Digital Health Global
OCTOBER 23, 2023
Believes Nymox Management and Board Must Be Held Accountable for Prolonged Underperformance and Egregious Governance Practices Urges Shareholders to Vote on the WHITE Proxy Card to Install New Leadership and a New Board at Upcoming Special Meeting CARSON CITY, Nev. &
Lloyd Price
OCTOBER 24, 2018
Sir John's decision to leave his role was to avoid any potential conflicts of interest that may arise from his role advising the government on the Life Sciences Industrial Strategy. Charles Swingland will step in as chairman on an interim basis before returning to his non-executive director position when a new chairman is found.
Expert insights. Personalized for you.
88 
Let's personalize your content